Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Ahrens B, Müller-Oerlinghausen B, Schou M, Wolf T, Alda M, Grof E, Grof P, Lenz G, Simhandl C, Thau K, Wolf R, Moller HJ (1995) Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis. J Aff Disord 33: 67–75
Angst J, Weis P, Grof P, Baastrup PC, Schou M (1970) Lithiumprophylaxis in recurrent affective disorders. Brit J Psychiatry 11: 604–614
Baastrup PC (1964) The use of lithium in manic-depressive psychosis. Comp Psychiatry 5: 396–408
Baastrup PC, Schou M (1967) Lithium as a prophylactic agent: its effect against recurrent depressions and manic-depressive psychosis. Arch Gen Psychiatry 16:162-172 Baastrup PC, Schou M (1968) Prophylactic lithium. Lancet i: 1419–1422
Baastrup PC, Poulsen JC, Schou M, Thomsen K, Amdisen A (1970) Prophylactic lithium: double-blind discontinuation in manic-depressive and recurrent depressive disorders. Lancet 2: 326–330
Blackwell B, Shepherd M (1968) Prophylactic lithium: another therapeutic myth? An examination of the evidence to date. Lancet i: 968–971
Cade JFJ (1949) Lithium salts in the treatment of psychotic-excitement. Med J Aust 36: 349–352
Coppen A, Noguera R, Bailey J, Burns BH, Swami MS, Hare EH, Gardner R, Maggs R (1971) Prophylactic lithium in affective disorders: controlled trial. Lancet 2: 275–279
Coppen A, Coppen A, Standish-Barry H, Bailey J, Houston G, Silcocks P, Hermon C (1991) Does lithium reduce the mortality of recurrent mood disorders? J Aff Disord 23: 1–7
Felber W, Kyber A (1994) Suizide and Parasuizide während and aul3erhalb einer Lithium-Prophylaxe. In: Müller-Oerlinghausen B, Berghöfer A (Hrsg.) Ziele and Ergebnisse der medikamentosen Prophylaxe affektiver Psychosen. Thieme, Stuttgart, S. 53–59
Gitlin MJ (1993) Lithium-induced renal insufficiency. J Clin Psychopharmacol 13:276M–279
Greil W, Ludwig-Mayerhofer W, Steller B, Czernik A, Giedke H, Müller-Oerlinghausen B, Osterheider M, Rudolf GAE, Sauer H, Tegeler J, Wetterling T (1993) The recruitment process for a multicenter study on the longterm prophylactic treatment of afMüllerfective disorders. J Aff Disord 28: 257–265
Greil W, Ludwig-Mayerhofer W, Steller B, Czernik A, Giedke H, Müller-Oerlinghausen B, Osterheider M, Rudolf GAE, Sauer H, Tegeler J, Wetterling T (1994) Lithiumoder Carbamazepinprophylaxe bei affektiven Psychosen? Ergebnisse einer kontrollierten, multizentrischen Studie. In: Müller-Oerlinghausen B, Berghofer A (Hrsg.) Ziele and Ergebnisse der medikamentosen Prophylaxe affektiver Psychosen. Thieme, Stuttgart, S. 113–119
Greil W, Ludwig-Mayerhofer W, Erazo N, Engel RR, Czernik A, Giedke H, Müller-Oer-linghausen B, Osterheider M, Rudolf GAE, Sauer H, Tegeler J, Wetterling T (1996) Comparative efficacy of lithium and amitriptyline in the maintenance treatment of recurrent unipolar depression: a randomized study. J Aff Disord 40: 179–190
Hammond WA (1871) A Treatise on Diseases of the Nervous System. Appleton & Co., New York, p. 381
Hartigan GP (1963) The use of lithium salts in affective disorders. Brit J Psychiatry 109: 810–814
Kallner G, Petterson U, (1995) Renal, thyroid and parathyroid function during lithium treatment: laboratory tests in 207 people treated for 1-30 years. Acta Psychiatr Scand 91: 48–51
Knorring von L, Wahlin A, Nystrom K, Bohman SO (1990) Uraemia induced by longterm lithium treatment. Lithium 1: 251–253
Lange C (1886) Om periodiske Depressionstilstande og deres Patogenese. Lunds Forlag, Copenhagen
Lange F (1894) De vigtigste Sindssygdomegrupper i kort Omrids. Gyldendal, Copenhagen
Lange C (1896) Periodische Depressionszustande and ihre Pathogenese auf dem Boden der harnsauren Diathese. Leopold Voss, Hamburg Leipzig
Lange C (1897) Bidrag til Urinsyrediatesens Klinik. Hospitalstidende 5: 1–83
Lenz G, Ahrens B, Denk E, Müller-Oerlinghausen B, Schratzberger-Topitz A, Simhandl C, Wancata J (1994) Mortalitat nach Ausscheiden aus der Lithiumambulanz. In: Müller-Oerlinghausen B, Berghofer A (Hrsg.) Ziele and Ergebnisse der medikamentosen Prophylaxe affektiver Psychosen. Thieme, Stuttgart, S. 49–52
Müller-Oerlinghausen B, Ahrens B, Volk J, Grof P, Grof E, Schou M, Vestergaard P, Lenz G, Simhandl C, Thau K, Wolf R (1991) Reduced mortality of manic-depressive patients in long-term lithium treatment: and international collaborative study by IGSLi. Psychiat Res 36: 329–331
Müller-Oerlinghausen B, Ahrens B, Grof E, Grof P, Lenz G, Schou M, Simhandl C, Thau K, Volk J, Wolf R, Wolf T (1992a) The effect of long-term lithium treatment on the mortality of patients with manic-depressive or schizo-affective illness. Acta Psychiatr Scand 86: 218–222
Müller-Oerlinghausen B, Miiser-Causemann B, Volk J (1992b) Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication. J Aff Disord 25: 261–270
Müller-Oerlinghausen B, Wolf T, Ahrens B, Schou M, Grof E, Grof P, Lenz G, Simhandl C, Thau K, Wolf R (1994) Mortality during initial and during later lithium treatment: a collaborative study by the International Group for the Study of Lithiumtreated Patients (IGSLi). Acta Psychiatr Scand 90: 295–297
A (1995) Mortality in recurrent mood disorders during periods on and off lithium: a complete population study in 362
patients. Pharmacopsychiatry 28:8–13
Schou M (1956) Lithiumterapi ved mani. Nord Med 55: 790–794
Schou M (1963) Normothymotics, „mood-normalizers”: are lithium and the imipramine drugs specific for affective disorders? Brit J Psychiatry 109: 803–809
Schou M (1973) Prophylactic lithium maintenance treatment in recurrent endogenous affective disorders. In: Gershon S, Shopsin B (eds) Lithium. Its role in psychiatric research and treatment. Plenum, New York, London, 269–294
Schou M (1988) Effects of long-term lithium treatment on kidney function: an overview. Psychiatr Res 22: 287–296
Schou M (1993a) Personal observation
Schou M (1993b) Lithium prophylaxis: about ‘naturalistic’ or clinical ‘practice’ studies. Lithium 4: 77–81
Schou M (1993b) Lithium prophylaxis: about ‘naturalistic’ or clinical ‘practice’ studies. Lithium 4:77–81
Schou M, Juel-Nielsen N, Stromgren E, Voldby H (1954) The treatment of manic psychoses by the administration of lithium salts. J Neurol Neurosurg Psychiatry 17: 250–260
Thies-Flechtner K, Seibert W, Walther A, Greil W, Müller-Oerlinghausen B (1994) Suizide bei rezidivprophylaktisch behandelten Patienten mit affektiven Psychosen. In: Müller-Oerlinghausen B, Berghöfer A (Hrsg.) Ziele and Ergebnisse der medikamentösen Prophylaxe affektiver Psychosen. Thieme, Stuttgart, S. 61–64
Waller DG, Edwards JG (1989) Lithium and the kidney: an update. Psychol Med 19: 825–831
Wing AJ, Brunner FP, Geerlings W, Broyer M, Brynger H, Fassbinder W, Rissoni G, Selwood NH, Tufeson G (1989) Contribution of toxic nephropathies to end-stage renal failure in Europe: a report from the EDTA-ERA registry. Toxicol Lett 46:281M–292
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schou, M. (1997). Der historische Hintergrund der Lithiumtherapie and -prophylaxe. In: Müller-Oerlinghausen, B., Berghöfer, A., Greil, W. (eds) Die Lithiumtherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60819-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-60819-3_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64570-9
Online ISBN: 978-3-642-60819-3
eBook Packages: Springer Book Archive